UNIQUE EXPERTISE
Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
UNIQUE CAPABILITIES
We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.
OUR PUBLICATIONS
We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.
NEWS
deCODE Receives California Clinical Laboratory License
Californians can now enjoy the benefits of deCODE’s market-leading DNA-based disease risk assessment tests and pioneering deCODEme™ genome scans Reykjavik, ICELAND, February 19, 2009 – deCODE genetics (Nasdaq:DCGN) today announced that it has received a clinical...
Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack
Genetic variants influencing white blood cell counts are linked to increased risk of heart attack and asthma; variants are being integrated into deCODEme™ Reykjavik, ICELAND, February 9, 2009 – In a paper published today, scientists at deCODE genetics (Nasdaq:DCGN)...
Award by the American Society of Human Genetics
At its Annual meeting in October 2017 in Orlando, the American Society of Human Genetics (ASHG), presented Dr. Kári Stefánsson, founder and CEO of deCODE genetics, with the William Allan Award. The award, the top prize given by the society, recognizes a scientist for substantial and far-reaching scientific contributions to human genetics. The ASHG has distributed video footage from the award ceremony. The introduction is given by Professor Mark Daly of Harvard University.